SUMER JACQUELYN L — SEC Form 4 filings
SEC reporting owner CIK 1844824. 9 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-23 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 18,061 shares, $208,492 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 3,601 shares @ $14.47 ($52,106) in Cullinan Therapeutics, Inc., filed 2026-02-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | Chief Legal Officer | 9 | — | 5 legs · 18,061 sh · $208,492 | 6 |
Form 4 filings — SUMER JACQUELYN L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 2,470 @ $8.60 | EDGAR |
| 2026-02-25 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 3,601 @ $14.47 | EDGAR |
| 2026-02-23 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 3,742 @ $13.62 | EDGAR |
| 2026-02-19 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 230,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 3,480 @ $9.67 | EDGAR |
| 2025-02-27 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 3,756 @ $8.53 | EDGAR |
| 2025-02-21 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 3,482 @ $11.41 | EDGAR |
| 2024-02-23 | 4 | Cullinan Oncology, Inc. (CGEM) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1844824 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →